Advanced Single Domain Antibody (SdAb) Discovery for Membrane Protein

Background Platform Workflow Target Classes Application Advantage Related Services FAQ Online Inquiry

For over two decades, Creative Biolabs has been a global leader in pioneering antibody engineering solutions. We proudly offer our specialized Single Domain Antibody (SdAb) Discovery Service targeting membrane proteins, one of the most challenging yet valuable target classes. By harnessing the unique properties of camelid-derived V_HH antibodies and integrating state-of-the-art platforms, we empower researchers to unlock novel therapeutic and diagnostic avenues. Our services are tailored to overcome the traditional hurdles of membrane protein antibody development, delivering high-affinity, high-specificity SdAbs ready for your downstream applications.

Discuss Your Project Today

The Unparalleled Advantage of SdAbs for Targeting Membrane Proteins

Membrane proteins, such as G-protein coupled receptors (GPCRs), ion channels, and transporters, constitute over 60% of modern drug targets. However, their complex structures, low expression levels, and instability outside the native lipid bilayer make them notoriously difficult targets for conventional antibodies (IgGs). Single domain antibodies, the smallest functional antigen-binding fragments derived from camelid heavy-chain-only antibodies, offer a revolutionary solution. Their unique features make them exceptionally suited for membrane protein research.

Overcoming the Challenges of Membrane Protein Antibody Discovery

Creative Biolabs directly addresses the core difficulties in this field with a multi-platform strategy.

Challenge	Creative Biolabs' Advanced Solution
Low Immunogenicity	DNA Immunization & VLP Display: We employ genetic immunization with optimized expression codons for your target, ensuring in vivo expression and presentation of the membrane protein in its native conformation, maximizing the immune response.
Protein Purification Difficulty	Cell-Based Immunization & Screening: We can immunize camelids (llamas, alpacas) with cells overexpressing the target protein, bypassing the need for complex and often denaturing protein purification steps.
Maintaining Native Conformation	Proprietary Membrane Protein Selection Platform: Our screening strategies, including advanced FACS sorting and biopanning on live cells, are designed to exclusively select for SdAbs that recognize the correctly folded, functional state of the membrane protein.
Limited Epitope Access	Diverse Library Construction & Deep Screening: We generate hyper-immune libraries with vast diversity (up to 10^10). Coupled with Next-Generation Sequencing (NGS), we perform deep mining of the antibody repertoire to identify rare clones binding to unique functional sites.

Our State-of-the-Art Membrane Protein SdAb Discovery Platforms

We offer a suite of world-class technology platforms to build a customized project plan for your success.

Advanced Camelid Immunization Strategies

Our foundation is a robust immunization strategy using llamas and alpacas. Depending on your target's nature, we offer multiple paths:

DNA Immunization: The gold standard for multi-transmembrane proteins. We deliver the gene encoding your target, allowing for in vivo expression and presentation in its native form.
Protein/Peptide Immunization: Ideal for targets where purified protein or specific extracellular domain peptides are available.
Whole-Cell Immunization: Using engineered cell lines overexpressing the membrane protein of interest. This is highly effective for preserving native conformations.
Virus-Like Particle (VLP) Display: Presenting your membrane protein on the surface of VLPs to elicit a potent and highly targeted immune response.

Unrivaled Library Construction and Screening Technologies

From an immunized camelid, we construct high-quality immune libraries and employ powerful screening technologies to isolate the perfect binder.

Phage Display Platform: A robust and proven method. We construct V_HH phage display libraries and perform multiple rounds of biopanning against your target, whether it's a purified protein, a peptide, or presented on live cells.
Yeast Display Platform: The preferred choice for selecting high-affinity binders. By displaying the V_HH library on the surface of yeast and using quantitative FACS sorting, we can isolate antibodies with exceptional affinity and favorable biophysical properties.
Next-Generation Sequencing (NGS) for SdAb Discovery: We have fully integrated NGS into our workflow. This allows us to analyze the entire antibody repertoire before, during, and after selection, ensuring no valuable clone is missed and providing deep insights into the clonal diversity and convergence of the immune response.

Our Integrated Anti- Membrane Proteins SdAb Discovery Workflow

Phase 1: Project Consultation & Strategy Design

In-depth discussion of the membrane protein target (GPCR, ion channel, etc.).
Selection of the optimal immunization and screening strategy.

Phase 2: Immunization & Immune Response Monitoring

Immunization of llamas or alpacas using the chosen strategy (DNA, Cell, etc.).
Regular monitoring of titer levels via ELISA to confirm a successful immune response.

Phase 3: V_HH Library Construction & Screening

Extraction of PBMCs from the immunized animal.

Construction of a hyper-immune phage or yeast display library (Diversity > 10^9).
Multiple rounds of stringent biopanning/FACS screening to enrich for specific binders.

Phase 4: Hit Identification and Characterization

High-throughput screening (ELISA, FACS) of hundreds of clones.
Sequencing of positive hits and bioinformatics analysis (NGS optional for deep mining).

Phase 5: Recombinant SdAb Expression and Characterization

Subcloning of unique V_HH sequences into expression vectors.
Small-to-large-scale recombinant expression and purification.
Comprehensive characterization including affinity measurement (SPR/BLI), specificity testing, and stability analysis.

Phase 6: Final Report and Deliverables

Delivery of purified, high-affinity SdAbs.
Complete dataset, sequence information, and a comprehensive final report.

Target Classes We Specialize In

Our team has extensive experience in developing SdAbs against a wide array of challenging membrane protein classes:

G-Protein Coupled Receptors (GPCRs): Including Class A, B, C, and F. We can generate agonists, antagonists, and allosteric modulators
Ion Channels: Targeting voltage-gated, ligand-gated, and other channel families
Transporters: Including ABC transporters and solute carriers (SLCs)
Receptor Tyrosine Kinases (RTKs)
Immune Checkpoints: Such as PD-L1, CTLA-4, and emerging targets

Fig. 1 Scheme of membrane protein. (Creative Biolabs Authorized). Fig. 1 Membrane protein.

Applications of Membrane Protein-Specific SdAbs

The SdAbs developed at Creative Biolabs can be powerful tools for a range of applications:

Structural Biology: As crystallization chaperones to stabilize membrane proteins and facilitate X-ray crystallography or Cryo-EM studies.
Therapeutic Development: As blocking/activating agents, or as targeting moieties for CAR-T, ADCs, and other bi-specific formats.
In Vitro & In Vivo Imaging: Easily conjugated to fluorescent dyes or radionuclides for PET/SPECT imaging.
Advanced Diagnostics: Development of highly sensitive and specific diagnostic assays (ELISA, lateral flow).
Biosensors: Functionalization of sensor surfaces for real-time binding kinetics.

Why Choose Creative Biolabs?

20+ Years of Focused Expertise: Unmatched experience in antibody engineering and membrane protein biology.
Customized Project Design: We are your scientific partners, designing a strategy that fits your specific goals and budget.
Guaranteed Results: We offer milestone-based projects with a commitment to delivering high-quality, functional SdAbs.
Transparent Communication: Regular updates and direct access to our expert scientists throughout your project.
Cutting-Edge Technology: Continuous investment in the latest platforms like NGS and advanced display technologies to ensure the highest success rates.

Related Featured SdAb Discovery Services

Explore our specialized services to advance your research:

Contact our team of experts today to discuss your project. Let us show you how our advanced single domain antibody discovery services can accelerate your research and development.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQ)

Q: What is the typical timeline for a membrane protein SdAb discovery project?

A: While timelines vary based on complexity, a standard project from immunization to delivery of characterized hits typically takes 4-6 months.

Q: What kind of starting material do I need to provide?

A: This depends on the strategy. It could be as simple as a gene sequence for DNA immunization, or an established cell line overexpressing your target. We will guide you through the requirements.

Q: Can you generate SdAbs that modulate the function of a GPCR or ion channel?

A: Yes. Our screening platforms can be tailored with functional assays (e.g., calcium flux, cAMP assays) to specifically isolate functional modulators (agonists/antagonists).

Q: Are the V_HH antibodies you generate royalty-free?

A: We offer flexible business models, including royalty-free options for research use and clear licensing terms for commercial development. Please inquire for details.

Reference

Qin, Qian, et al. "Single domain antibody application in bacterial infection diagnosis and neutralization." Frontiers in Immunology 13 (2022): 1014377. https://doi.org/10.3389/fimmu.2022.1014377

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.